12:00 AM
 | 
Nov 05, 2001
 |  BC Extra  |  Company News

Icos licenses Afferon's RTX

ICOS exclusively licensed from Afferon (Wayne, Penn.) worldwide rights to RTX resiniferatoxin to treat urological disorders....

Read the full 61 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >